Injectable Manufacturing Services

 

Category: *CDMO

Exhibitor: FORMOSA LABORATORIES, INC.

Booth No: M314

 

Characteristic

 

We provide one-stop solutions for sterile injectable drug products to our customers. Our state-of-the-art injectable manufacturing facility and team of dedicated experts are capable to provide services from contract development to commercial manufacturing.

-Injectable facilities for cytotoxic, non-cytotoxic and highly potent drugs
-Small molecules and biologics filling for pre-filled syringe and vial (PFS, vial) and lyophilization
-Excellent sterility assurance level provided by barrier isolator technology
-An advantage for oxidization sensitive biologics with low hydrogen peroxide (H2O2) residual design based

One Stop Solution Services
-From Chemicals to Pharmaceuticals
-From IND to NDA/ANDA/BLA filing
-From Lab to Commercial manufacturing

Injectable Plant
Our injectable facility accommodates both small molecules and biologics, from pilot scale to commercial scale, and all under regulated or cytotoxic control.
For the non-cytotoxics, one pilot scale line and one commercial scale line enable us to serve our client from clinical stage to commercialization while the dedicated cytotoxic line provides sufficient capacity to supply for clients’ target markets all around the world. Equipped with lyophilizer for each line, Formosa Lab offers manufacturing of aseptically filling liquid and lyophilized products.

Injectable Facilities
The aseptic filling processes in our non-cytotoxic lines are integrated from ready-to-use vials, ready-to-use syringes, and sterilized vials and syringes through capping while the cytotoxic line can handle sterilized vials and syringes with broad range of sizes and configurations. Our state-of-the-art injectable manufacturing facility and team of dedicated experts are capable to provide services from contract development to commercial manufacturing for Drugs :
 Both Small Molecules and Biologics
 General, Cytotoxic, and High potenct
 Liquid-filled, Lyophilized and Pre-filled syringe
With the capacity that can serve
 Pilot to Commercial scale
 Aseptic Filling, Terminal Sterilization when required.
 Broad range of sizes and configurations.
 Disposable (single-use system) manufacturing options

 

Other Products

 

• 

  Active Pharmaceutical Ingredients (APIs)

• 

  Antibody Drug Conjugates (ADCs)

• 

  Contract Development and Manufacturing Organization (CDMO)

 

 

 

Back